PeerView | Genetics

Free CME from PeerView

Genetics CME

Credits: 1 CME / MOC / NCPD / CPE

PVI, PeerView Institute for Medical Education

Making New Strides in Hypertrophic Cardiomyopathy: The Latest Guidelines, Science, and Strategies for Early Diagnosis and Tailored Treatment

Neal K. Lakdawala, MD, Anjali Tiku Owens, MD

November 12, 2021

Credits: 1 CME / MOC / CC

Medical Learning Institute, Inc.

Time for Even More Precision in Testing and Treatment of EGFR-Mutated NSCLC: Refining and Expanding Best Practices in Advanced and Early-Stage Disease Settings

Lynette M. Sholl, MD

October 28, 2021

Credits: 0.5 CME

Medical Learning Institute, Inc.

On the Cusp of a New Targeted Treatment Era in ALS: Exploring the Emerging Therapeutic Landscape

October 21, 2021

Credits: 1.00 CME / MOC / NCPD / CPE

Heart Failure Society of America

Easing the Burden of Hypertrophic Cardiomyopathy: Progress in Understanding and Addressing Its Pathophysiology

Daniel Jacoby, MD

October 1, 2021

Credits: 1.50 CME / MOC / CC

Medical Learning Institute, Inc.

Target Practice: Understanding How PARP Inhibitors Take Aim at DNA Damage Response Mutations Across Solid Tumors

Susana Banerjee, MBBS, MA, FRCP, PhD

May 7, 2021

Credits: 0.50 CME

Medical Learning Institute, Inc.

Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy

Karl E. Anderson, MD

April 15, 2021

Credits: 1.00 CME

Medical Learning Institute, Inc.

New Milestones and Changing Standards of Care in EGFR-Mutated NSCLC: Expanding the Benefits of Genomic Testing and EGFR-Targeted Therapy to Early-Stage Lung Cancer

March 9, 2021

Medical Learning Institute, Inc.

Targeting DNA Repair Defects Through PARP Inhibition in Prostate Cancer: Rationale, Evidence, and Clinical Implications

Emmanuel S. Antonarakis, MD

July 22, 2020

Medical Learning Institute, Inc.

Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency

Robin Lachmann, MD, PhD / Melissa Wasserstein, MD

June 3, 2020

Medical Learning Institute, Inc.

Targeting Pathogenic Mutations in the DNA Damage Response Pathway: Genetic Testing and Counseling in the Era of Precision Medicine and Next-Generation Sequencing

Mike Janicek, MD / Bradley J. Monk, MD, FACS, FACOG

May 27, 2020

Medical Learning Institute, Inc.

Novel Strategies and Emerging Evidence to Address Unmet Needs in Treating Patients With Long-Chain Fatty Acid Oxidation Disorders

Jerry Vockley, MD, PhD

January 31, 2020